HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu V Mareev Selected Research

Coronavirus Infections

7/2023[Androgenic status of men with severe COVID-19: the role of testosterone and dihydrotestosterone [within the program FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)]].
12/2022Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19).
11/2022
10/2022The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study).
12/2021[Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity].
3/2021Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
3/2021Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
12/2020[How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID)].
12/2020[Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronŠ°virUs Infection requiring hospiTalization (BISCUIT)].
10/2020[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu V Mareev Research Topics

Disease

12Coronavirus Infections
07/2023 - 01/2020
11COVID-19
07/2023 - 01/2020
9Heart Failure
03/2024 - 09/2019
7Inflammation (Inflammations)
07/2023 - 01/2020
4Infections
07/2023 - 04/2020
4Thrombosis (Thrombus)
07/2023 - 01/2020
3Dyspnea (Shortness of Breath)
07/2023 - 03/2021
3Pneumonia (Pneumonitis)
12/2022 - 01/2020
3Fever (Fevers)
12/2022 - 12/2020
3Venous Thrombosis (Deep-Vein Thrombosis)
03/2022 - 01/2020
3Viral Pneumonia
03/2021 - 12/2020
2Disease Progression
03/2024 - 12/2022
2Atrial Fibrillation
02/2023 - 04/2022
2Cytokine Release Syndrome
12/2022 - 01/2020
2Chronic Cough
12/2022 - 03/2021
1Hyperthermia
07/2023
1Shock
07/2023
1Kidney Diseases (Kidney Disease)
02/2023
1Cardiovascular Diseases (Cardiovascular Disease)
02/2023
1Hypertriglyceridemia
02/2023
1Chronic Renal Insufficiency
02/2023
1Arthralgia (Joint Pain)
10/2022
1Obesity
10/2022
1Chronic Disease (Chronic Diseases)
10/2022
1Neoplasms (Cancer)
03/2022
1Venous Thromboembolism
03/2022
1Body Weight (Weight, Body)
07/2021
1Edema (Dropsy)
01/2021
1Viremia
12/2020
1Gout
10/2020
1Fibrosis (Cirrhosis)
09/2020
1Lung Injury
01/2020
1Thromboembolism
01/2020

Drug/Important Bio-Agent (IBA)

5fibrin fragment D (D-dimer)IBA
07/2023 - 01/2020
5C-Reactive ProteinIBA
12/2022 - 01/2020
3CytokinesIBA
07/2023 - 01/2020
3RNA (Ribonucleic Acid)IBA
12/2022 - 12/2020
3ruxolitinibIBA
12/2022 - 10/2020
3secukinumabIBA
12/2022 - 10/2020
3ColchicineFDA LinkGeneric
12/2022 - 10/2020
3Oxygen (Dioxygen)IBA
12/2022 - 03/2021
3AnticoagulantsIBA
04/2022 - 10/2020
2AndrogensIBA
07/2023 - 12/2021
2Testosterone (Sustanon)FDA Link
07/2023 - 12/2021
2AngiotensinsIBA
07/2021 - 04/2020
2ReninIBA
07/2021 - 04/2020
2AldosteroneIBA
07/2021 - 04/2020
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
03/2021 - 09/2020
2Spironolactone (Aldactone)FDA LinkGeneric
12/2020 - 09/2020
2Bromhexine (Bisolvon)IBA
12/2020 - 09/2020
2ChemokinesIBA
10/2020 - 01/2020
1Dihydrotestosterone (Androstanolone)IBA
07/2023
1Fibrinogen (Factor I)FDA Link
07/2023
1vericiguatIBA
05/2023
1Triglycerides (Triacylglycerol)IBA
02/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2023
1Coenzymes (Enzyme Cofactors)IBA
06/2022
1coenzyme Q10 (CoQ10)IBA
06/2022
1apixabanIBA
03/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2022
1Mineralocorticoid Receptor AntagonistsIBA
07/2021
1Sodium-Glucose Transport ProteinsIBA
07/2021
1Angiotensin Receptor AntagonistsIBA
07/2021
1Neprilysin (Neutral Endopeptidase)IBA
07/2021
1Antimalarials (Antimalarial Agents)IBA
03/2021
1DiureticsIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
1Interleukin-6 (Interleukin 6)IBA
10/2020
1Interleukin-17 (Interleukin 17)IBA
10/2020
1Janus KinasesIBA
10/2020
1tocilizumab (atlizumab)FDA Link
10/2020
1LopinavirFDA Link
09/2020
1remdesivirIBA
09/2020
1favipiravirIBA
09/2020
1Antiviral Agents (Antivirals)IBA
09/2020
1Peptide Hydrolases (Proteases)FDA Link
09/2020
1Ritonavir (Norvir)FDA Link
09/2020
1Angiotensin II Type 1 Receptor BlockersIBA
04/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2020
1MethylprednisoloneFDA LinkGeneric
01/2020
1Hormones (Hormone)IBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1SteroidsIBA
01/2020
1pro-brain natriuretic peptide (1-76)IBA
11/2019

Therapy/Procedure

14Therapeutics
07/2023 - 09/2019
2Drug Therapy (Chemotherapy)
03/2024 - 05/2021
1Duration of Therapy
12/2021
1Aftercare (After-Treatment)
03/2021
1Length of Stay
12/2020